Termination, Asset Transfer and Transition Agreement Sample Contracts

TERMINATION, ASSET TRANSFER AND TRANSITION AGREEMENT BETWEEN NAPO PHARMACEUTICALS, INC. AND GLENMARK PHARMACEUTICALS, LTD. DATED SEPTEMBER 22, 2017

Termination, Asset Transfer and Transition Agreement • November 20th, 2017 • Jaguar Health, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Termination, Asset Transfer and Transition Agreement
• Filed
  November 20th, 2017
• Company
  Jaguar Health, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

THIS TERMINATION, ASSET TRANSFER AND TRANSITION AGREEMENT (this “Agreement”) dated as of September 22, 2017 (“Transfer Date”), is entered into between Napo Pharmaceuticals, Inc., a wholly-owned subsidiary of Jaguar Health, Inc., a Delaware corporation having its principal place of business at 201 Mission Street, Ste. 2375, San Francisco, California 94105 (“Napo”), and Glenmark Pharmaceuticals, Ltd., a company organized under the laws of the Republic of India having its principal place of business at Glenmark House, B D Sawant Marg, Chakala, Off Western Express Highway Andheri (E), Mumbai - 400099 (“Glenmark”).